Chloroquine Phosphate and Hydroxychloroquine Sulfate USP Testing
SGS Polymer Solutions provides USP testing of chloroquine phosphate and hydroxychloroquine sulfate in our cGMP compliant lab.
SGS Polymer Solutions provides USP testing of chloroquine phosphate and hydroxychloroquine sulfate in our cGMP compliant lab.
Chloroquine phosphate is the phosphate salt of chloroquine which is a quinoline compound. Derivatives of chloroquine are used in the treatment of malaria, rheumatoid arthritis, some forms of lupus, and other medical maladies.
SGS Polymer Solutions provides testing of chloroquine phosphate (50-63-5), hydroxychloroquine sulfate (747-36-4), and hydroxychloroquine sulfate tablets in accordance with their relevant United States Pharmacopeia (USP) monographs. The testing will be performed in our cGMP compliant testing lab.
Identification confirmation is accomplished by using a series of analytical method in accordance with the corresponding USP Monographs. Those methods may include FTIR, UV-Vis spectroscopy, and wet chemistry methods.
Assay and impurity methods are performed by a combination of titrations, UV-Vis, and liquid chromatography methods.
Loss on drying is required for chloroquine phosphate and hydroxychloroquine sulfate. This determines the loss of volatile matter under specified conditions.
Uniformity of dosage units <905> of the hydroxychloroquine phosphate tablets will be calculated from assays of a representative sample batch.
Contact us to discuss your specific sample requirements for chloroquine phosphate, hydroxychloroquine sulfate, or hydroxychloroquine sulfate tablets based on the specific USP tests you would like to have performed.
SGS Polymer Solutions has conducted USP analysis in our FDA registered laboratory for pharmaceutical clients. The testing is performed in our cGMP compliant laboratory.
Related Services